Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19

Figure 1 Total coronavirus disease 2019 cases and nonalcoholic fatty liver disease prevalence. United States of America 25439570, India 10689527, Brazil 8933356, Russia 3716228, United Kingdom 3700268, France 3138498, Spain 2629817, Italy 2485956, Turkey 2442350, Germany 2164043.

Figure 2 Coronavirus disease 2019 case fatality rate and nonalcoholic fatty liver disease prevalence. Mexico 8.5%, Peru 3.6%, Italy 3.5%, South Africa 2.9%, Indonesia 2.8%, United Kingdom 2.7%, Colombia 2.6%, Argentina 2.5%, Germany 2.5% and Brazil 2.5%. The prevalence of nonalcoholic fatty liver disease in those countries is indicated by the colored circles.

Figure 3 Number of deaths from coronavirus disease 2019 per 100000 habitants and nonalcoholic fatty liver disease prevalence. United Kingdom 150.94, Czechia 146.98, Italy 143.01, United States of America 129.94, Peru 125.38, Spain 121.55, Mexico 120.47, France 110.84, Portugal 107.10, Argentina 106.20.